Knect 365 Life Sciences’ 9th Annual ASIA Oligonucleotide and Peptide Therapeutics Conference and Exhibition (TIDES) will be held from February 21st to 23rd in Westin Miyako Kyoto, Kyoto, Japan. The exploitation strategies of oligonucleotide and peptide drugs and the latest research achievements will be shared and exhibited while research and develop tendency in the future will be discussed by leaders from oligonucleotide and peptide fields all over the world for improving the conversion rate of scientific and technological achievements and enhancing substantive cooperation.RiboBio is looking forward to your visit andenquiry in No. A17 booth with globally leading oligonucleotide cGMP services and related products.
Date: 21/02/2017 – 23/02/2017
Conference Location: Westin Miyako Kyoto, Kyoto, Japan
Booth Number: A17
Since 2004, RiboBio has been always focusing on nucleic acids-based drug discovery and manufacture, established a nation-leading platform in nucleic acids drug development and the first cGMP oligonucleotide manufacturing facility by virtue of our leading-edge technologies. The drug discovery platform has built a complete research and development system from nucleic acids-drug design to animal studies, which included high-throughput design and synthesis laboratory, high-throughput high content screening laboratory, and animal efficacy and pharmacology laboratory, biological analysis and pharmacokinetics laboratory. We can offer the first class CRO services for nucleic acids-based drug discovery. The manufacturing facility has oligonucleotides process development laboratory, GMP oligonucleotides manufacturing suite, and oligonucleotide drugs quality control laboratory. We have provided high quality manufacturing services and CMC services of oligonucleotides drug. In recent years, RiboBio has been completed several oligonucleotide GMP manufacturing projects for several well-known pharmaceutical companies.